EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Discovery of ROCK2 inhibitors through computational screening of ZINC database: Integrating pharmacophore modeling, molecular docking, and MD simulations

Abdullah R Alanzi iD, Abdelaaty A Shahat iD, Bayan Abdullah Alhaidhal iD, Raghad Mohammad Aloatibi

PLOS One · 13.05.2025 · 20 (5) · e0323781

DOI: 10.1371/journal.pone.0323781 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 13.05.2025. Verfasst von Abdullah R Alanzi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia. Hauptthemen laut MEDLINE: rho-Associated Kinases, Molecular Docking Simulation, Molecular Dynamics Simulation, Protein Kinase Inhibitors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rho-associated protein kinase 2 (ROCK2) is a serine/threonine kinase that is crucial for regulating various physiological processes and is part of the Rho-associated coiled-coil kinase family. The dysregulation of ROCK2 has been associated with a range of diseases, making it a promising target for therapy. In this study, a chemical feature-based pharmacophore model was developed on the co-crystal ligand (5YS) of ROCK2 to conduct the virtual screening of ZINC database, resulting in 4809 hits that were further subjected to molecular docking to find the binding affinities with ROCK2 protein. The binding affinities of the hits were analyzed and compounds in the range of -11.55 to -9.91 kcal/mol were selected for further analysis. The ADMET analysis identified two promising compounds, whose binding stability with the ROCK2 protein was further evaluated using molecular dynamics (MD) simulations. Simulation results revealed that the selected compounds remained closely bound to protein indicating that they can act as lead compounds to control the biological activity of ROCK2. However, further in vitro investigation is required to test the biological efficacy of the reported compounds.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

rho-Associated KinasesMolecular Docking SimulationMolecular Dynamics SimulationProtein Kinase InhibitorsDrug DiscoveryHumansLigandsProtein BindingDrug Evaluation, PreclinicalPharmacophore

Substanzen

rho-Associated KinasesROCK2 protein, humanProtein Kinase InhibitorsLigands

Autor:innen und Institutionen

  • Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.

ORCID-Profile: Abdullah R Alanzi, Abdelaaty A Shahat, Bayan Abdullah Alhaidhal

Zitieren

APA

Alanzi, A. R., Shahat, A. A., Alhaidhal, B. A., & Aloatibi, R. M. (2025). Discovery of ROCK2 inhibitors through computational screening of ZINC database: Integrating pharmacophore modeling, molecular docking, and MD simulations. PLOS One, 20(5), e0323781. https://doi.org/10.1371/journal.pone.0323781

Vancouver

Alanzi AR, Shahat AA, Alhaidhal BA, Aloatibi RM. Discovery of ROCK2 inhibitors through computational screening of ZINC database: Integrating pharmacophore modeling, molecular docking, and MD simulations. PLOS One. 2025;20(5):e0323781. doi:10.1371/journal.pone.0323781

BibTeX
@article{Alanzi2025,
  author = {Alanzi, Abdullah R and Shahat, Abdelaaty A and Alhaidhal, Bayan Abdullah and Aloatibi, Raghad Mohammad},
  title = {Discovery of ROCK2 inhibitors through computational screening of ZINC database: Integrating pharmacophore modeling, molecular docking, and MD simulations},
  journal = {PLOS One},
  year = {2025},
  volume = {20},
  number = {5},
  pages = {e0323781},
  doi = {10.1371/journal.pone.0323781}
}
Kostenlos starten →